Arbiter: Are platinum compounds mandatory in the treatment of metastatic non-small cell lung cancer?

被引:1
作者
Giaccone, G [1 ]
机构
[1] Free Univ Amsterdam Hosp, Dept Med Oncol, NL-1081 HV Amsterdam, Netherlands
关键词
D O I
10.1016/S0959-8049(98)00311-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1997 / 1999
页数:3
相关论文
共 12 条
[1]   SURVIVAL DETERMINANTS IN EXTENSIVE-STAGE NON-SMALL-CELL LUNG-CANCER - THE SOUTHWEST-ONCOLOGY-GROUP EXPERIENCE [J].
ALBAIN, KS ;
CROWLEY, JJ ;
LEBLANC, M ;
LIVINGSTON, RB .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (09) :1618-1626
[2]  
ALBERTI W, 1995, BRIT MED J, V311, P899
[3]  
Bonomi P, 1996, P AN M AM SOC CLIN, V15, P382
[4]   CARBOPLATIN DOSAGE - PROSPECTIVE EVALUATION OF A SIMPLE FORMULA BASED ON RENAL-FUNCTION [J].
CALVERT, AH ;
NEWELL, DR ;
GUMBRELL, LA ;
OREILLY, S ;
BURNELL, M ;
BOXALL, FE ;
SIDDIK, ZH ;
JUDSON, IR ;
GORE, ME ;
WILTSHAW, E .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (11) :1748-1756
[5]  
CARDENAL F, 1997, P AN M AM SOC CLIN, V16, pA458
[6]  
Giaccone G, 1996, BRIT J HOSP MED, V55, P634
[7]   RANDOMIZED STUDY OF VINORELBINE AND CISPLATIN VERSUS VINDESINE AND CISPLATIN VERSUS VINORELBINE ALONE IN ADVANCED NON-SMALL-CELL LUNG-CANCER - RESULTS OF A EUROPEAN MULTICENTER TRIAL INCLUDING 612 PATIENTS [J].
LECHEVALIER, T ;
BRISGAND, D ;
DOUILLARD, JY ;
PUJOL, JL ;
ALBEROLA, V ;
MONNIER, A ;
RIVIERE, A ;
LIANES, P ;
CHOMY, P ;
CIGOLARI, S ;
GOTTFRIED, M ;
RUFFIE, P ;
PANIZO, A ;
GASPARD, MH ;
RAVAIOLI, A ;
BESENVAL, M ;
BESSEN, F ;
MARTINEZ, A ;
BERTHAUD, P ;
TURSZ, T .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (02) :360-367
[8]   RANDOMIZED COMPARISON OF 2 COMBINATION REGIMENS VERSUS MINIMAL CHEMOTHERAPY IN NONSMALL-CELL LUNG-CANCER - A SOUTHEASTERN CANCER STUDY-GROUP TRIAL [J].
LUEDKE, DW ;
EINHORN, L ;
OMURA, GA ;
SARMA, PR ;
BARTOLUCCI, AA ;
BIRCH, R ;
GRECO, FA .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (05) :886-891
[9]  
ROSSO R, 1990, CANCER-AM CANCER SOC, V66, P130, DOI 10.1002/1097-0142(19900701)66:1<130::AID-CNCR2820660123>3.0.CO
[10]  
2-P